BioNxt Solutions Inc. (CSE:BNXT)

Canada · Delayed Price · Currency is CAD

0.4100

-0.0100 (-2.38%)

May 21, 2026, 10:43 AM EST

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals			372.25K	297.44K	286.50K	345.65K	208.12K
Pharmaceuticals Growth			25.15%	3.82%	-17.11%	66.08%	-
Total			372.25K	297.44K	286.50K	345.65K	208.12K
Total Growth			25.15%	3.82%	-17.11%	66.08%	-

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Austria			81.70K	267.36K	112.36K	-	-
Austria Growth			-69.44%	137.95%	-	-	-
Germany			19.52K	21.15K	129.02K	345.65K	208.12K
Germany Growth			-7.70%	-83.61%	-62.67%	66.08%	-
Switzerland			3.53K	3.47K	3.41K	-	-
Switzerland Growth			1.93%	1.61%	-	-	-
Korea			267.50K	-	-	-	-
Israel			-	5.47K	-	-	-
USA			-	-	41.71K	-	-
Total			372.25K	297.44K	286.50K	345.65K	208.12K
Total Growth			25.15%	3.82%	-17.11%	66.08%	-

Source: S&P Global Market Intelligence.